FDA Inspection 1335568 — Carle Health Care Inc Reproductive Reproductive Windsor
The FDA completed an inspection of Carle Health Care Inc Reproductive Reproductive Windsor on Aug 24, 2026 in Urbana, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 24, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Urbana, IL (United States)